Skip to main content
logo
Eupraxia Pharmaceuticals Inc. (EPRX)
NASDAQ: EPRX · Real-Time Price · USD
6.10
+0.29 (4.99%)
Jul 27, 2026, 9:41 AM EDT - Market open

Eupraxia Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
3813811121115828
Market Cap Growth
106.59%241.41%0.65%90.50%111.19%-
Enterprise Value
27432210296438
Last Close Price
5.817.553.174.162.692.30

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
2.804.743.51124.328.081.83
P/TBV Ratio
3.537.2965.7050.067.481.75

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.020.000.0011.711.250.52
Net Debt / Equity Ratio
-1.00-1.00-1.04-9.96-1.29-1.04
Net Debt / EBITDA Ratio
2.912.101.230.320.531.12
Net Debt / FCF Ratio
4.092.761.100.430.631.31
Quick Ratio
18.9514.4410.741.016.0013.38
Current Ratio
19.3015.1211.101.026.0813.49
Return on Equity (ROE)
-54.52%-68.76%-157.31%-715.19%-178.04%-
Return on Assets (ROA)
-33.84%-39.67%-61.14%-88.37%-52.20%-68.51%
Return on Capital Employed (ROCE)
-34.30%-47.70%-84.80%-3120.70%-109.70%-61.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-12.32%-10.12%-22.84%-25.44%-31.75%-68.66%
FCF Yield
-8.77%-7.64%-26.96%-18.77%-25.12%-43.73%
Buyback Yield / Dilution
-26.83%-17.76%-40.52%-25.21%-55.45%-102.75%
SEC Filings: 10-K · 10-Q